Newsy's Latest Health News

The U.S. government, in collaboration with Kaiser Health News, plans to purchase 1.25 million doses of Regeneron's COVID-19 antibody cocktail to treat high-risk patients. Meanwhile, Israel is implementing coronavirus immunity passports for those vaccinated, allowing them to bypass isolation after exposure or travel. Special thanks to Kaiser Health News for their contributions.

What is the purpose of the Trump administration's purchase of additional Regeneron doses?

• To stockpile for future pandemics

• To treat high-risk, non-hospitalized COVID patients

• To distribute to other countries

• To use in clinical trials

What is the main feature of Israel's coronavirus immunity passports?

• They provide free healthcare services

• They allow unrestricted travel worldwide

• They exempt holders from wearing masks

• They permit holders to avoid isolation after exposure

What condition must be met to receive Israel's green booklet?

• Receiving one dose of the vaccine

• Having a history of COVID-19 infection

• Receiving two doses of the vaccine

• Testing negative for COVID-19

What percentage of Israel's population has been vaccinated according to the transcript?

• 25%

• 10%

• 15%

• 20%

Who is acknowledged for providing the health headlines in the transcript?

• World Health Organization

• Centers for Disease Control and Prevention

• National Institutes of Health

• Kaiser Health News